NCT02909114

Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

Phase II Study of Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Jing Jin, M.D. · Unknown
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer

Detailed description

Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer, the primary concerns are treatment efficacy and toxicities.

Conditions

• Colorectal Cancer

Interventions

Type	Name	Description
RADIATION	Stereotactic body radiotherapy	All patients will undergo planning CT simulation. 4-dimensional CT will be used for tumors in the lungs or liver. For all lesions, the gross tumor volume (GTV) will be defined as the visible tumor on CT and/or MRI imaging +/- PET. A Planning Target Volume (PTV) margin of 3-5 mm will be added depending on site of disease, immobilization, and institutional set-up accuracy. The prescirbe dosage was as following: Lung lesion DT50-60 Gy/5 fractions; liver 50-60Gy/5-8 fractions; brain DT 40Gy/4-5fractions. All will be treated with SBRT

Timeline

• Start date: 2016-01-01
• Primary completion: 2020-12-01
• Completion: 2020-12-01
• First posted: 2016-09-21
• Last updated: 2016-09-21

Locations

1 site across 1 country: China